Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial

Cécile Tromeur, Olivier Sanchez, Emilie Presles, Gilles Pernod, Laurent Bertoletti, Patrick Jego, Elisabeth Duhamel, Karine Provost, Florence Parent, Philippe Robin, Lucile Deloire, Florent Leven, Fanny Mingant, Luc Bressollette, Pierre-Yves Le Roux, Pierre-Yves Salaun, Michel Nonent, Brigitte Pan-Petesch, Benjamin Planquette, Philippe Girard, Karine Lacut, Solen Melac, Patrick Mismetti, Silvy Laporte, Guy Meyer, Dominique Mottier, Christophe Leroyer, Francis Couturaud

Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017
Journal Issue: January
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cécile Tromeur, Olivier Sanchez, Emilie Presles, Gilles Pernod, Laurent Bertoletti, Patrick Jego, Elisabeth Duhamel, Karine Provost, Florence Parent, Philippe Robin, Lucile Deloire, Florent Leven, Fanny Mingant, Luc Bressollette, Pierre-Yves Le Roux, Pierre-Yves Salaun, Michel Nonent, Brigitte Pan-Petesch, Benjamin Planquette, Philippe Girard, Karine Lacut, Solen Melac, Patrick Mismetti, Silvy Laporte, Guy Meyer, Dominique Mottier, Christophe Leroyer, Francis Couturaud. Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial. Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021
Year: 2022



Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Risk factors in patients with venous thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 239s
Year: 2002

Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case?control study from Sweden
Source: Eur Respir J , 49 (2) 1601014; DOI: 10.1183/13993003.01014-2016
Year: 2017



Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
Source: Eur Respir J 2016; 47: 369-373
Year: 2016


Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005


Clinical presentation and outcome of venous thromboembolism in COPD
Source: Eur Respir J 2012; 39: 862-868
Year: 2012



Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study
Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017
Year: 2017



Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010


Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review
Source: Eur Respir J 2015; 45: 201-210
Year: 2015



Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020


Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism
Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018
Year: 2018



Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006

Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Source: Eur Respir J 2016; 48: 1369-1376
Year: 2016



Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study
Source: Eur Respir J 2014; 44: 1714-1715
Year: 2014


Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing
Source: Eur Respir J 2016; 47:1313-1314
Year: 2016